Latest Strategic Reset News

ANZ reported a 10% decline in statutory profit for FY2025, impacted by significant regulatory and restructuring charges, while reaffirming its ANZ 2030 strategy and maintaining a strong capital position.

Epsilon Healthcare has commenced operations of its new pharmacy division and extended a key loan facility, signaling a strategic pivot towards integrated healthcare and financial stability after recent restructuring.

Noumi Limited reported a 13% rise in adjusted operating EBITDA for FY25, driven by strong growth in its Milklab plant-based milk brand, while preparing for a significant convertible note maturity in 2027.

OzAurum Resources reports strong drilling results at its Mulgabbie North Gold Project and regains full control of its Feasibility Study, positioning the company for accelerated development amid record gold prices.

Pure Foods Tasmania reported a $1 million operating cash outflow in the September quarter due to restructuring and timing factors but anticipates positive cash flow and growth driven by new Coles product launches and operational efficiencies.

McPherson’s Limited updates shareholders on its ongoing transformation journey, reporting modest core brand growth in FY25 and outlining a strategic outlook for FY26 focused on sustainable expansion and operational efficiency.

Helios Energy has restarted production at its Texas Presidio wells and identified new drilling targets, setting the stage for a dual-track development strategy that balances early cashflow with longer-term growth.

Winchester Energy reported a slight dip in production but secured a strategic 30% farm-out deal for its Varn waterflood project, alongside significant board restructuring.

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

OzAurum Resources reports significant high-grade gold intercepts at its Mulgabbie North project and regains full control of its feasibility study, positioning the company to accelerate development amid record gold prices.

Opthea has significantly reduced its operating costs and settled a key financial liability, positioning itself for a strategic review aimed at unlocking shareholder value.

Mach7 Technologies reports a modest rise in recurring revenue alongside a comprehensive commercial transformation, positioning itself for growth in AI-driven medical imaging.